Get the robot in here, STAT! Surgery is going digital by leveraging artificial intelligence, telemedicine, and big data to bring cutting edge care to patients across the globe. David Fischel is CEO of Stereotaxis (NYSEAMERICAN:STXS), one of the companies leading this sea change. He dropped by the NYSE to talk about the company’s advancements, including bringing Genesis, a new robotic magnetic navigation technology, to market. David also forecasts the future of machine-augmented medicine and how Stereotaxis provide the tools that surgeons will need in the operating rooms of the future.